Industry News
Pharmaceutical Industry News
How agentic AI is transforming…
How agentic AI is transforming market research in the pharmaceutical industry
AI-driven insights, patient…
AI-driven insights, patient support and omnichannel engagement key to future success
Wasserman says…
Wasserman says hyper-personalization and data-driven insights are reshaping pharma marketing
Eying a multiple sclerosis drug…
Eying a multiple sclerosis drug that it has tabbed with peak annual sales potential of $12 billion in the U.S. alone, Zenas BioPharma has struck a licensing deal with China-based InnoCare Pharma that could be
With a pair of new athletic…
With a pair of new athletic partnerships under its belt, Vanda Pharmaceuticals is suiting up as a multisport player.
The U.K. government is in…
The U.K. government is in "advanced talks" with the U.S. and aims to fend off potential tariffs by raising its standard cost-effectiveness threshold for new medicines, according to Politico.
Ahead of ESMO, Astellas shares its…
Ahead of ESMO, Astellas shares its vision to transform cancer care – bringing hope through science to patients living with the hardest-to-treat cancers
Vifor Pharma is letting go of 55…
Vifor Pharma is letting go of 55 employees who report to the Swiss company’s primary U.S. office in King of Prussia, Pennsylvania, just outside Philadelphia, according to a Worker Adjustment and Retraining Notification Act report
A U.S. advertising self-regulatory…
A U.S. advertising self-regulatory body has told Galderma to drop or change a claim about how quickly Nemluvio provides itch relief, triggered by a complaint from competitor Sanofi.
Johnson & Johnson Ordered to Pay $966 Million in Latest Talc Lawsuit
The case involves a California woman who died from mesothelioma, a rare cancer. Her family claimed Johnson and Johnson’s talc powder products were to blame.
Boehringer’s Jascayd is the first…
Boehringer's Jascayd is the first new drug to break into the idiopathic pulmonary fibrosis field in more than a decade, following in the footsteps of the company's 2014-approved blockbuster Ofev.
This year has brought a range of…
This year has brought a range of challenges for biopharma companies and their leaders, including on-and-off tariff threats and President Donald Trump's arm-twisting around overseas drug spending. Now, new data show how industry leaders are
Parents Struggle to Find Covid Vaccines for Their Children Amid Regulatory Confusion
Children under 12 need different versions of Covid vaccines, but many pharmacies and pediatricians’ offices aren’t stocking them.
A Los Angeles court found Johnson…
A Los Angeles court found Johnson & Johnson liable in a case brought by a woman who died from mesothelioma in 2021. With its decision, a jury ordered the company to pay $966 million to
Novartis polled more than 3,000…
Novartis polled more than 3,000 women to gauge how their thoughts and feelings about their breasts impact their breast health, discovering five findings that could offer insight into what's needed to encourage more conversations on
AbbVie is going back to school to…
AbbVie is going back to school to support patients with inflammatory bowel disease, enrolling “Abbott Elementary” star Tyler James Williams for a new campaign aimed at sparking deeper conversations about long-term IBD treatment goals.
Brad Bacon discusses access…
Brad Bacon discusses access challenges, direct-to-patient shifts and the role of trust in care
Less than two months after OXB…
Less than two months after OXB revealed a plan to expand its operations in the U.S., the U.K.-based cell and gene therapy manufacturer has purchased a viral vector plant in North Carolina from National Resilience
Join Fierce Pharma as we sit down…
Join Fierce Pharma as we sit down with industry innovators to explore the most impactful strategies, cutting-edge insights, and collaborative approaches shaping the future of pharma engagement.
The specialty pharmacy industry is…
The specialty pharmacy industry is in a state of transformation, fueled by the rise of complex, innovative therapies and the critical need for more robust patient support.